Creatine supplementation lowers brain glutamate levels in Huntington's disease

Bender, A.; Auer, D. P.; Merl, T.; Reilmann, R.; Saemann, P.; Yassouridis, A.; Bender, J.; Weindl, A.; Dose, M.; Gasser, T.; Klopstock, T.

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Creatine supplementation lowers brain glutamate levels in Huntington's disease

MPS-Authors

/persons/resource/persons80257

Auer, D. P.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80441

Merl, T.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80505

Saemann, P.
AG Czisch, Michael, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80601

Yassouridis, A.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80266

Bender, J.
AG Deussing, Jan, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Bender, A., Auer, D. P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., Bender, J., Weindl, A., Dose, M., Gasser, T., & Klopstock, T. (2005). Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology, 252(1), 36-41.

引用: https://hdl.handle.net/11858/00-001M-0000-000E-9B4F-E

要旨

要旨はありません